Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |